DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20202716

Effectiveness of bundled interventions in reducing surgical site infections in elective caesarean sections and caesarean hysterectomies in a tertiary care centre

Gunjan Yadav, Kalpana Yadav, Parasuram Waddar

Abstract


Background: Surgical site infections are the most common and easily preventable infections complicating surgeries. CDC recommends certain bundle interventions for the prevention of SSIs. Hence the present study was undertaken to see the effectiveness and feasibility of the bundle interventions in the elective caesarean sections and caesarean hysterectomies.

Methods: A total of 600 patients were taken. Bundled interventions were applied in 278 caesarean sections and 26 caesarean hysterectomies. Routine care was implemented in 262 caesarean sections and 34 caesarean hysterectomies. Rate of SSI, risk factors associated and treatment outcomes were studied.

Results: 8 out of 304 cases of the bundled intervention group developed SSI, giving a rate of 2.6%. 52 cases out of 296 in the routine care group developed SSI, the SSI rate being 17.5%. Anemia and diabetes were the most common risk factors.

Conclusions: Adherence to bundled interventions can significantly and easily reduce the incidence of SSI.


Keywords


Bundled intervention, Caesarean hysterectomy, Caesarean sections, Surgical site infections

Full Text:

PDF

References


National Healthcare Safety Network, Centers for Disease Control and Prevention. Surgical site infection (SSI) event. Available at: http://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf. Accessed on 25th January 2017.

Cheadle WG. Risk factors for surgical site infection. Surg Infect. 2006;7 (supplement 1):S7-S11.

Anderson DJ, Podgorny K, Berrios-Torres SI, Bratzler DW, Dellinger EP, Greene L, et al, Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35:605-27.

Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al, Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195-283.

Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999;20:247-78.

Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al, Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370:1198-208.

The federation of obstetric and gynaecological societies of India. Fogsi.org. 2019. Available at: https://www.fogsi.org/fogsi-cesarean-rates-jdt. Accessed on 20th October 2019.

Lippitt MH, Fairbairn MG, Matsuno R, Stone RL, Tanner III EJ, Wick EC, et al. Outcomes associated with a five-point surgical site infection prevention bundle in women undergoing surgery for ovarian cancer. Obstet Gynecol. 2017;130(4):756-64.

Taylor JS, Marten CA, Munsell MF, Sun CC, Potts KA, Burzawa JK, et al. The disinfect initiative: decreasing the incidence of surgical infections in gynecologic oncology. Ann Surg Oncol. 2017;24(2):362-8.

Mahdi H, Gojayev A, Buechel M, Knight J, SanMarco J, Lockhart D, et al. Surgical site infection in women undergoing surgery for gynecologic cancer. Int J Gynecol Cancer. 2014;24(4):779-86.

Bakkum-Gamez JN, Dowdy SC, Borah BJ, Haas LR, Mariani A, Martin JR, et al. Predictors and costs of surgical site infections in patients with endometrial cancer. Gynecol Oncol. 2013;130(1):100-6.

O’Donnell RL, Angelopoulos G, Beirne JP, Biliatis I, Bolton H, Bradbury M, et al. Impact of surgical site infection (SSI) following gynaecological cancer surgery in the UK: a trainee-led multicentre audit and service evaluation. BMJ Open. 2019;9(1):e024853.

Schiavone MB, Moukarzel L, Leong K, Zhou QC, Afonso AM, Iasonos A, et al. Surgical site infection reduction bundle in patients with gynecologic cancer undergoing colon surgery. Gynecol Oncol. 2017;147(1):115-9.

Tran CW, McGree ME, Weaver AL, Martin JR, Lemens MA, Cliby WA, et al. Surgical site infection after primary surgery for epithelial ovarian cancer: predictors and impact on survival. Gynecol Oncol. 2015;136(2):278-84.

Nugent EK, Hoff JT, Gao F, Massad LS, Case A, Zighelboim I, et al. Wound complications after gynecologic cancer surgery. Gynecol Oncol. 2011;121(2):347-52.

Van Nguyen JM, Sadeghi M, Gien LT, Covens A, Kupets R, Nathens AB, et al. Impact of a preventive bundle to reduce surgical site infections in gynecologic oncology. Gynecol Oncol. 2019;152(3):480-5.